Wendling D, Racadot E, Augé B, Toussirot E
Service de Rhumatologie, C.H.R.U., Hôpital Jean Minjoz, Besançon, France.
Clin Rheumatol. 1998;17(3):202-4. doi: 10.1007/BF01451047.
The aim of the study was to evaluate the soluble form of intercellular adhesion molecule 1 (sICAM-1), a ligand of LFA-1, in the serum of patients with spondylarthropathies (SpA) and to look for a correlation with several inflammatory parameters. sICAM-1 levels were measured by ELISA in 25 SpA patients, 20 healthy controls and 20 patients with rheumatoid arthritis (RA). Results showed that sICAM-1 levels were increased (but not significantly) in SpA patients compared with controls; high levels (> 400 ng/ml) where found in 28% of SpA patients but in none of the RA or control groups. In SpA, correlations were found between sICAM-1 and erythrocyte sedimentation rate, C-reactive protein and interleukin 6, but not with tumour necrosis factor alapha or IgA. These correlations were absent in RA. In conclusion, these results suggest that sICAM-1 levels in SpA may reflect the acute phase of inflammation.
本研究旨在评估细胞间黏附分子1(sICAM-1)的可溶性形式(淋巴细胞功能相关抗原1的一种配体)在脊柱关节病(SpA)患者血清中的水平,并寻找其与多种炎症参数的相关性。采用酶联免疫吸附测定法(ELISA)检测了25例SpA患者、20例健康对照者及20例类风湿关节炎(RA)患者的sICAM-1水平。结果显示,与对照组相比,SpA患者的sICAM-1水平升高(但无统计学意义);28%的SpA患者sICAM-1水平较高(>400 ng/ml),而RA组和对照组均未发现此类情况。在SpA患者中,sICAM-1与红细胞沉降率、C反应蛋白及白细胞介素6之间存在相关性,但与肿瘤坏死因子α或IgA无相关性。RA患者中不存在这些相关性。总之,这些结果提示,SpA患者的sICAM-1水平可能反映炎症急性期。